These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 27533046

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Head-to-head comparison of humoral immune responses to Vi capsular polysaccharide and Salmonella Typhi Ty21a typhoid vaccines--a randomized trial.
    Kantele A, Pakkanen SH, Karttunen R, Kantele JM.
    PLoS One; 2013; 8(4):e60583. PubMed ID: 23593253
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Efficacy of typhoid vaccines against culture-confirmed Salmonella Typhi in typhoid endemic countries: a systematic review and meta-analysis.
    Batool R, Qamar ZH, Salam RA, Yousafzai MT, Ashorn P, Qamar FN.
    Lancet Glob Health; 2024 Apr; 12(4):e589-e598. PubMed ID: 38485426
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.
    Wang JY, Noriega FR, Galen JE, Barry E, Levine MM.
    Infect Immun; 2000 Aug; 68(8):4647-52. PubMed ID: 10899868
    [Abstract] [Full Text] [Related]

  • 29. Re-examination of immune response and estimation of anti-Vi IgG protective threshold against typhoid fever-based on the efficacy trial of Vi conjugate in young children.
    Szu SC, Klugman KP, Hunt S.
    Vaccine; 2014 Apr 25; 32(20):2359-63. PubMed ID: 24630869
    [Abstract] [Full Text] [Related]

  • 30. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH, Kantele JM, Herzog C, Kantele A.
    Vaccine; 2014 Jan 23; 32(5):544-51. PubMed ID: 24342246
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
    Bhutta ZA, Capeding MR, Bavdekar A, Marchetti E, Ariff S, Soofi SB, Anemona A, Habib MA, Alberto E, Juvekar S, Khan RM, Marhaba R, Ali N, Malubay N, Kawade A, Saul A, Martin LB, Podda A.
    Lancet Infect Dis; 2014 Feb 23; 14(2):119-29. PubMed ID: 24290843
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The Impact of Vaccination and Prior Exposure on Stool Shedding of Salmonella Typhi and Salmonella Paratyphi in 6 Controlled Human Infection Studies.
    Gibani MM, Voysey M, Jin C, Jones C, Thomaides-Brears H, Jones E, Baker P, Morgan M, Simmons A, Gordon MA, Cerundolo V, Pitzer VE, Angus B, Levine MM, Darton TC, Pollard AJ.
    Clin Infect Dis; 2019 Apr 08; 68(8):1265-1273. PubMed ID: 30252031
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH, Kantele JM, Kantele A.
    Vaccine; 2012 Sep 14; 30(42):6047-53. PubMed ID: 22858557
    [Abstract] [Full Text] [Related]

  • 40. Vaccines for preventing typhoid fever.
    Engels EA, Lau J.
    Cochrane Database Syst Rev; 2000 Sep 14; (2):CD001261. PubMed ID: 10796623
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.